Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial.

Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 2018 12; 6(12):925-933.

View in: PubMed

subject areas

Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Albuminuria
Amine Oxidase (Copper-Containing)
Cell Adhesion Molecules
Creatinine
Diabetic Nephropathies
Double-Blind Method
Enzyme Inhibitors
Female
Follow-Up Studies
Glomerular Filtration Rate
Humans
Male
Middle Aged
Organic Chemicals
Prognosis
Young Adult